AURA Overview
Upcoming Projects (AURA)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (AURA)
-
A Third Look: Discussing the cretostimogene grenadenorepvec data as it continues to demonstrate best-in-class durability of response as well as consistent and compelling safety and efficacy
Tickers: CGON, TARA, AURA, PFE
Executed On: Apr 11, 2025 at 08:15 AM EDT -
A Second Look: Discussing the cretostimogene grenadenorepvec data as it continues to demonstrate best-in-class durability of response as well as consistent and compelling safety and efficacy
Tickers: CGON, TARA, AURA, PFE
Executed On: Apr 10, 2025 at 05:00 PM EDT -
Discussing the cretostimogene grenadenorepvec data as it continues to demonstrate best-in-class durability of response as well as consistent and compelling safety and efficacy
Tickers: CGON, TARA, AURA, PFE
Executed On: Apr 09, 2025 at 12:00 PM EDT -
Third View: Discussing Aura Biosciences Inc's early data from an ongoing Phase 1 clinical trial of bel-sar (AU-011) in patients with Non-Muscle-Invasive Bladder Cancer (NMIBC).
Ticker: AURA
Executed On: Nov 13, 2024 at 12:00 PM EST -
Second View: Discussing Aura Biosciences Inc's early data from an ongoing Phase 1 clinical trial of bel-sar (AU-011) in patients with Non-Muscle-Invasive Bladder Cancer (NMIBC).
Ticker: AURA
Executed On: Nov 07, 2024 at 02:00 PM EST -
Discussing Aura Biosciences Inc's early data from an ongoing Phase 1 clinical trial of bel-sar (AU-011) in patients with Non-Muscle-Invasive Bladder Cancer (NMIBC).
Ticker: AURA
Executed On: Nov 06, 2024 at 08:00 AM EST -
Discussing the interim data from Phase 2 trial of Belzupacap sarotalocan (AURA-1101) in choroidal melanoma
Ticker: AURA
Executed On: Nov 17, 2022 at 05:00 PM EST
Upcoming & Overdue Catalysts (AURA)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (AURA)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
